Urticaria Chronic
·MeSH: Chronic Urticaria
Prevalence
1088.5 / 100K
Incidence
1908.5 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| briquilimab | Jasper Therapeutics Inc. (JSPR) |
Frequently asked questions
How many drugs are in development for Urticaria Chronic?
BioSniper tracks 1 drug in development for Urticaria Chronic across 1 company.
How many clinical trials target Urticaria Chronic?
There are 1 clinical trial targeting Urticaria Chronic tracked by BioSniper.
What is the prevalence of Urticaria Chronic?
The estimated prevalence of Urticaria Chronic is approximately 1088.5 per 100,000 population.
Deep-dive into Urticaria Chronic
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis